728x90
반응형
Classification criteria for catastrophic antiphospholipid antibody syndrome (CAPS)
Criteria |
1. Evidence of involvement of three or more organs, systems, and/or tissues |
2. Development of manifestations simultaneously or in less than a week |
3. Confirmation by histopathology of small vessel occlusion in at least one organ or tissue |
4. Laboratory confirmation of the presence of antiphospholipid antibodies (lupus anticoagulant, anticardiolipin antibodies, and/or anti-beta2-glycoprotein I antibodies) |
Classification |
Definite catastrophic APS |
Requires all four criteria |
Probable catastrophic APS |
All four criteria, except for only two organs, systems, and/or sites of tissue involvement or |
All four criteria, except for the laboratory confirmation at least six weeks apart due to the early death of a patient never tested for aPL before the catastrophic APS or |
Criteria 1, 2, and 4 above or |
1, 3, and 4 and the development of a third event in more than a week but less than a month, despite anticoagulation |
aPL: antiphospholipid antibodies.
Adapted from: Asherson, RA, Cervera, R, de Groot, PG, et al. Lupus 2003; 12:530.
728x90
반응형
'류마티스내과 > 서론' 카테고리의 다른 글
구강궤양에 멀티비타민을 복용하면 낫지 않을까? (0) | 2019.10.28 |
---|---|
재발성 아프타 구강 궤양 치료, Recurrent aphthous stomatitis (RAS), treatment (0) | 2019.10.28 |
레이노드 증후군에서 사포그릴레이트, Sarpogrelate in Raynaud phenomenon (0) | 2019.05.10 |
Role of on-demand sildenafil for Raynaud phenomeno (0) | 2019.05.06 |
비스테로이드성 소염제, 약물학, 록소프로펜(록소닌), NSAIDs, pharmacology, loxoprofen(loxonin) (0) | 2019.03.19 |